SBC Medical Group HD CEO Yoshiyuki Aikawa Discusses “Strategy for No. 1 Customer Numbers in Japan,” “Naomi Issue,” and “One Year Since Nasdaq Listing” – Toyo Keizai Online

News Highlights

In an interview with Toyo Keizai Online, Yoshiyuki Aikawa, CEO of SBC Medical Group HD, reflected on the “No. 1 customer numbers in Japan” strategy, the past “Naomi issue,” and the one-year anniversary of their Nasdaq listing. The group focuses on multi-site expansion, primarily in aesthetic medicine, emphasizing marketing strategies for customer acquisition and initiatives to foster a sense of unity within the organization. The company’s management strategy, which continues to expand its business even after listing, offers many valuable insights for managers of various medical institutions.

M&A Medical Editorial Department’s Perspective

The “No. 1 customer numbers in Japan” strategy discussed by SBC Medical Group HD CEO Aikawa can be seen not merely as an expansion of scale, but as the result of meticulous business operations centered on customer satisfaction and repeat business. In particular, achieving over 1.7 million customer visits annually in the highly competitive field of aesthetic medicine suggests the critical importance of not only marketing investment but also treatment quality, brand image, and the overall design of the customer experience. When considering M&A or business succession for medical institutions, the quality and sustainability of the customer base, not just sales and profits, are essential factors for maximizing business value. For clinics struggling with succession issues, this strategy holds hidden clues on how to leverage their unique strengths in customer experience to connect with the next generation.

Key Discussion Points from This News

• SBC Medical Group HD’s pursuit of “No. 1 customer numbers in Japan” is a strategy focused on enhancing customer satisfaction and repeat business, rather than just scale.
• Achieving over 1.7 million customer visits annually in the aesthetic medicine sector highlights the importance of marketing investment and customer experience design.
• For medical institution M&A and business succession, the quality and sustainability of the customer base are crucial for maximizing business value.
• Management strategies that foster organizational unity and a consistent brand image are key success factors for multi-site medical groups.

Practical Questions Arising from This News

• What specific marketing initiatives and customer services are implemented to acquire and maintain over 1.7 million customer visits annually?
• What changes have occurred in organizational culture and management strategy since the Nasdaq listing?
• How has the organization addressed and overcome past challenges, such as the “Naomi issue”?

“Should I Consult About This?”

Your clinic’s strengths may lie not just in numbers like sales or patient volume, but in the “customer experience.” Like the case of SBC Medical Group HD, how can you strengthen your clinic’s customer base and pass it on to the next generation? When facing issues such as succession problems or business expansion, consider exploring business succession possibilities from the perspective of maximizing customer value, rather than just through M&A brokerage. We recommend consulting with an expert.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are handled with strict confidentiality. Free consultation here